BNP Paribas Knock-Out MRK 17.05.2.../ DE000PC41EL2 /
5/16/2024 9:50:13 PM | Chg.0.000 | Bid5/16/2024 | Ask5/16/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
9.550EUR | 0.00% | 9.550 Bid Size: 1,048 |
10.000 Ask Size: 1,000 |
MERCK KGAA O.N. | - EUR | 5/17/2024 | Call |
GlobeNewswire
12:00 AM
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/15
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VIS...
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA